Recent Updates
July 14, 2010
Avandia: GlaxoSmithKline agrees to settle before FDA vote
June 27, 2010
Underinsured Motorist (UIM) Claims
June 24, 2010
Zimmer Duron Cup Hip Replacement Cases
June 24, 2010
DePuy ASR Hip Replacements
April 20, 2010
Steve Leshner Is Named a Super Lawyer for 2010
Archives
July, 2010
June, 2010
October, 2009
September, 2009
June, 2009
February, 2009
January, 2009
December, 2008
September, 2008
August, 2008
Avandia
Posted by: euser
January 14, 2009
Topic: PRODUCT LIABILITY
According to a recent study conducted by researchers at the Harvard Medical School, elderly people with diabetes who took Avandia (rosiglitazone) were more likely to develop congestive heart failure and die, than people who took Actos(pioglitazone). Using a database of Medicare beneficiaries to track 28,361 patients over five years, half of whom took rosiglitazone, while the other half took pioglitazone, death rates were 15% higher in the patients who took rogiglitazone, and their congestive heart failure incidence was 13% higher. According to Wolfgang C. Winkelmayer, Assistant Professor of Medicine at the Harvard Medical School, and an author of the observational study, "Rosiglitazone was associated with greater mortality".
Both the American Diabetes Association and the European Association for the Study of Diabetes have removed rosiglitazone from the list of recommended treatments for type 2 diabetes. While sales of Avandia have fallen sharply, it remains on the market in the U.S. Public Citizen has called for the U.S. Food and Drug Administration to ban the drug, claiming it causes liver failure, vision impairment, and other serious side effects, in addition to heart problems.
If you or a loved one has taken Avandia, and suffered serious medical complications, please call me to discuss your options.
